loadpatents
Patent applications and USPTO patent grants for Tsantrizos; Youla S..The latest application filed is for "substituted bicyclic pyrimidine-based compounds and compositions and uses thereof".
Patent | Date |
---|---|
Substituted bicyclic pyrimidine-based compounds and compositions and uses thereof Grant 11,279,719 - Tsantrizos , et al. March 22, 2 | 2022-03-22 |
Substituted Bicyclic Pyrimidine-based Compounds And Compositions And Uses Thereof App 20190367542 - Tsantrizos; Youla S. ;   et al. | 2019-12-05 |
Heterocyclyl-pyridinyl-based biphosphonic acid, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof Grant 9,290,526 - Tsantrizos , et al. March 22, 2 | 2016-03-22 |
Heterocyclyl-pyridinyl-based Biphosphonic Acid, Pharmaceutically Acceptable Salt Thereof, Composition Thereof And Method Of Use Thereof App 20150376214 - TSANTRIZOS; Youla S. ;   et al. | 2015-12-31 |
Thienopyrimidine Inhibitors Of Farnesyl And/or Geranylgeranyl Pyrophosphate Synthase App 20150307532 - TSANTRIZOS; Youla S. ;   et al. | 2015-10-29 |
Inhibitors Of Human Immunodeficiency Virus Replication App 20140296228 - Tsantrizos; Youla S. ;   et al. | 2014-10-02 |
Inhibitors of human immunodeficiency virus replication Grant 8,841,331 - Yoakim , et al. September 23, 2 | 2014-09-23 |
Heterocyclyl-pyridinyl-based biphosphonic acid, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof Grant 8,816,082 - Tsantrizos , et al. August 26, 2 | 2014-08-26 |
Inhibitors of human immunodeficiency virus replication Grant 8,710,230 - Tsantrizos , et al. April 29, 2 | 2014-04-29 |
Heterocyclyl-pyridinyl-based Biphosphonic Acid, Pharmaceutically Acceptable Salt Thereof, Composition Thereof And Method Of Use Thereof App 20130203702 - Tsantrizos; Youla S. ;   et al. | 2013-08-08 |
Inhibitors Of Human Immunodeficiency Virus Replication App 20130203747 - Yoakim; Christiane ;   et al. | 2013-08-08 |
Inhibitors Of Human Immunodeficiency Virus Replication App 20130197231 - Tsantrizos; Youla S. ;   et al. | 2013-08-01 |
Inhibitors Of Human Immunodeficiency Virus Replication App 20130190491 - Tsantrizos; Youla S. ;   et al. | 2013-07-25 |
Inhibitors of human immunodeficiency virus replication Grant 8,461,180 - Tsantrizos , et al. June 11, 2 | 2013-06-11 |
Inhibitors of human immunodeficiency virus replication Grant 8,377,960 - Tsantrizos , et al. February 19, 2 | 2013-02-19 |
Inhibitors of human immunodeficiency virus replication Grant 8,354,429 - Tsantrizos , et al. January 15, 2 | 2013-01-15 |
Viral polymerase inhibitors Grant 8,076,365 - Tsantrizos December 13, 2 | 2011-12-13 |
Viral polymerase inhibitors Grant 8,030,309 - Tsantrizos , et al. October 4, 2 | 2011-10-04 |
Inhibitors of human immunodeficiency virus replication Grant 7,956,068 - Carson , et al. June 7, 2 | 2011-06-07 |
Inhibitors Of Human Immunodeficiency Virus Replication App 20110118249 - Tsantrizos; Youla S. ;   et al. | 2011-05-19 |
Inhibitors of human immunodeficiency virus replication Grant 7,939,545 - Tsantrizos , et al. May 10, 2 | 2011-05-10 |
Viral polymerase inhibitors Grant 7,893,084 - Beaulieu , et al. February 22, 2 | 2011-02-22 |
Hepatitis C inhibitor tri-peptides Grant RE42,164 - Llinas-Brunet , et al. February 22, 2 | 2011-02-22 |
Viral polymerase inhibitors Grant 7,888,363 - Beaulieu , et al. February 15, 2 | 2011-02-15 |
Inhibitors Of Human Immunodeficiency Virus Replication App 20110028464 - Tsantrizos; Youla S. ;   et al. | 2011-02-03 |
Viral polymerase inhibitors Grant 7,879,851 - Tsantrizos , et al. February 1, 2 | 2011-02-01 |
Viral Polymerase Inhibitors App 20110015203 - TSANTRIZOS; Youla S. ;   et al. | 2011-01-20 |
Inhibitors Of Human Immunodeficiency Virus Replication App 20100311735 - Tsantrizos; Youla S. ;   et al. | 2010-12-09 |
Inhibitors Of Human Immunodeficiency Virus Replication App 20100305115 - Carson; Rebekah J. ;   et al. | 2010-12-02 |
Hepatitis C inhibitor tri-peptides Grant RE41,894 - Llinas-Brunet , et al. October 26, 2 | 2010-10-26 |
Viral Polymerase Inhibitors App 20100168098 - Tsantrizos; Youla S. | 2010-07-01 |
Hepatitis C inhibitor tri-peptides Grant RE41,356 - Llinas-Brunet , et al. May 25, 2 | 2010-05-25 |
Inhibitors of papilloma virus Grant 7,582,766 - Tsantrizos , et al. September 1, 2 | 2009-09-01 |
Viral polymerase inhibitors Grant 7,582,770 - Tsantrizos , et al. September 1, 2 | 2009-09-01 |
Viral polymerase inhibitors Grant 7,576,079 - Beaulieu , et al. August 18, 2 | 2009-08-18 |
Viral Polymerase Inhibitors App 20090170859 - TSANTRIZOS; Youla S. ;   et al. | 2009-07-02 |
Viral Polymerase Inhibitors App 20090087409 - Beaulieu; Pierre Louis ;   et al. | 2009-04-02 |
Hepatitis C inhibitor tri-peptides Grant RE40,525 - Llinas-Brunet , et al. September 30, 2 | 2008-09-30 |
Inhibitors of human immunodeficiency virus replication App 20080221159 - TSANTRIZOS; Youla S. ;   et al. | 2008-09-11 |
Viral Polymerase Inhibitors App 20070249629 - BEAULIEU; Pierre ;   et al. | 2007-10-25 |
Viral polymerase inhibitors Grant 7,241,801 - Beaulieu , et al. July 10, 2 | 2007-07-10 |
Viral Polymerase Inhibitors App 20070142380 - Beaulieu; Pierre Louis ;   et al. | 2007-06-21 |
Viral polymerase inhibitors Grant 7,141,574 - Beaulieu , et al. November 28, 2 | 2006-11-28 |
Viral polymerase inhibitors App 20060160798 - Beaulieu; Pierre Louis ;   et al. | 2006-07-20 |
Viral polymerase inhibitors App 20060052418 - Beaulieu; Pierre ;   et al. | 2006-03-09 |
Viral polymerase inhibitors App 20050222236 - Tsantrizos, Youla S. ;   et al. | 2005-10-06 |
Inhibitors of papilloma virus App 20050014791 - Tsantrizos, Youla S. ;   et al. | 2005-01-20 |
Viral polymerase inhibitors Grant 6,841,566 - Beaulieu , et al. January 11, 2 | 2005-01-11 |
Viral polymerase inhibitors App 20040171626 - Beaulieu, Pierre Louis ;   et al. | 2004-09-02 |
Hepatitis C inhibitor peptides Grant 6,767,991 - Llinas-Brunet , et al. July 27, 2 | 2004-07-27 |
Viral polymerase inhibitors App 20040024190 - Beaulieu, Pierre Louis ;   et al. | 2004-02-05 |
Macrocyclic peptides active against the hepatitis C virus App 20040002448 - Tsantrizos, Youla S. ;   et al. | 2004-01-01 |
Viral polymerase inhibitors App 20030236251 - Beaulieu, Pierre Louis ;   et al. | 2003-12-25 |
Macrocyclic peptides active against the hepatitis C virus Grant 6,608,027 - Tsantrizos , et al. August 19, 2 | 2003-08-19 |
Hepatitis C inhibitor tri-peptides Grant 6,534,523 - Llinas-Brunet , et al. March 18, 2 | 2003-03-18 |
Hepatitis C inhibitor tri-peptides Grant 6,420,380 - Llinas-Brunet , et al. July 16, 2 | 2002-07-16 |
Hepatitis C inhibitor tri-peptides Grant 6,410,531 - Llinas-Brunet , et al. June 25, 2 | 2002-06-25 |
Hepatitis C inhibitor tri-peptides App 20020037998 - Llinas-Brunet, Montse ;   et al. | 2002-03-28 |
Hepatitis C inhibitor tri-peptides App 20020016442 - Llinas-brunet, Montse ;   et al. | 2002-02-07 |
Hepatitis C inhibitor tri-pepitides Grant 6,329,417 - Llinas-Brunet , et al. December 11, 2 | 2001-12-11 |
Hepatitis C inhibitor tri-peptides Grant 6,329,379 - Llinas-Brunet , et al. December 11, 2 | 2001-12-11 |
Hepatitis C inhibitor tri-peptides Grant 6,323,180 - Llinas-Brunet , et al. November 27, 2 | 2001-11-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.